We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+18.4%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.28B
AUM Growth
+$253M
Cap. Flow
+$143M
Cap. Flow %
11.17%
Top 10 Hldgs %
13.47%
Holding
1,446
New
471
Increased
321
Reduced
302
Closed
327

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$16.8M
2
U icon
Unity
U
+$14M
3
AIFC
AI Financial Corp
AIFC
+$13.8M
4
CYBR
CyberArk
CYBR
+$12.6M
5
NSC icon
Norfolk Southern
NSC
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 21.32%
2 Communication Services 11.38%
3 Healthcare 11.08%
4 Consumer Discretionary 10.37%
5 Financials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHYF
1351
DELISTED
The Shyft Group
SHYF
-16,000
Closed -$201K
SII
1352
Sprott
SII
$3.03B
-49,120
Closed -$3.39M
SILJ icon
1353
Amplify Junior Silver Miners ETF
SILJ
$3.85B
-11,757
Closed -$174K
SIRI icon
1354
SiriusXM
SIRI
$10.1B
-9,798
Closed -$225K
SJT
1355
San Juan Basin Royalty Trust
SJT
$118M
-396,709
Closed -$2.37M
SKX
1356
DELISTED
Skechers
SKX
-47,804
Closed -$3.02M
SLGN icon
1357
Silgan Holdings
SLGN
$4.41B
-12,834
Closed -$695K
SONY icon
1358
Sony
SONY
$138B
-17,350
Closed -$452K
SPOK icon
1359
Spok Holdings
SPOK
$241M
-148,185
Closed -$2.62M
SPTN
1360
DELISTED
SpartanNash
SPTN
-10,828
Closed -$287K
SRPT icon
1361
Sarepta Therapeutics
SRPT
$1.77B
-13,135
Closed -$225K
SRRK icon
1362
Scholar Rock
SRRK
$6.44B
-23,944
Closed -$848K
SSB icon
1363
SouthState Bank Corp
SSB
$10.5B
-3,074
Closed -$283K
SSBK
1364
DELISTED
Southern States Bancshares
SSBK
-27,408
Closed -$997K
SSNC icon
1365
SS&C Technologies
SSNC
$18.6B
-5,136
Closed -$425K
NSLR
1366
Neostellar Capital Corp
NSLR
$254M
-36,500
Closed -$300K
STM icon
1367
STMicroelectronics
STM
$50B
-70,200
Closed -$2.13M
STR
1368
DELISTED
Sitio Royalties
STR
-27,255
Closed -$501K
SVT
1369
DELISTED
Servotronics
SVT
-27,877
Closed -$1.31M
SWIM icon
1370
Latham Group
SWIM
$880M
-17,702
Closed -$113K
SWKS icon
1371
Skyworks Solutions
SWKS
$10.6B
-3,902
Closed -$291K
SWTX
1372
DELISTED
SpringWorks Therapeutics
SWTX
-171,716
Closed -$8.07M
TALK icon
1373
Talkspace
TALK
$874M
-15,100
Closed -$42K
TCMD icon
1374
Tactile Systems Technology
TCMD
$665M
-14,431
Closed -$146K
TDG icon
1375
TransDigm Group
TDG
$67.7B
-185
Closed -$281K

Similar funds

Prelude Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Prelude Capital Management held 1,446 positions worth $1.28B, up 25% from $1.03B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Prelude Capital Management deployed $143M of net new capital in Q3 2025, opening 471 new positions and adding to 321 existing holdings. Its largest new stake was Verona Pharma: 160,565 shares worth $17.1M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $13.2M trimmed.

  • Prelude Capital Management's largest Q3 2025 buy was Verona Pharma: 160,565 shares worth $17.1M.
  • Prelude Capital Management added most to Amazon in Q3 2025, an estimated $11.4M increase.
  • Prelude Capital Management's biggest Q3 2025 reduction was Meta Platforms (Facebook), cutting an estimated $13.2M.
  • Prelude Capital Management fully exited Amedisys in Q3 2025, selling an estimated $8.89M.
  • Prelude Capital Management's ten largest holdings make up 13% of its $1.28B portfolio in Q3 2025.
  • Prelude Capital Management opened 471 new positions and closed 327 in Q3 2025.
  • Prelude Capital Management's portfolio value rose 25% quarter-over-quarter to $1.28B.

Based on Prelude Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.